What Happened?
Pittsburgh, PA-based Peptilogics Appointed Jonathan Steckbeck as Founder, President and Chief Executive Officer
Date of management change: September 14, 2013
Pittsburgh, PA-based Peptilogics Appointed Jonathan Steckbeck as Founder, President and Chief Executive Officer
Peptilogics is a clinical-stage biotechnology company that designs and develops novel peptide therapeutics. Through their computational platform, Peptilogics is radically altering drug discovery by not only uncovering new, previously unexplored chemical design space, but ensuring that each potential therapeutic is biologically viable and scalable to manufacture. Peptilogics` lead clinical stage peptide therapeutic, PLG0206, is a novel, broad-spectrum anti-infective that has been granted FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation for its initial focus on the treatment of prosthetic joint infections, an unmet medical need.
Jonathan Steckbeck is Founder, President and Chief Executive Officer at Peptilogics. Previously, Jonathan held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Brant John, Johnson Dale, Strickland Jacqueline, George Ball, Huray Michael, Tomko Jennifer, Pelka Lorraine, King David, Webb Chris, Haxel Morgan, Milczarek Rebecca
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.